Last updated: 11/07/2018 18:39:56
A double-blind, randomised, parallel group, 12-week comparison of fluticasone propionate/salmeterol combination Diskus 100/50mcg BID with fluticasone propionate (FP) 250mcg BID as initial maintenance treatment in persistent asthma (Seretide Nordic Jump-Up Study)
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A double-blind, randomised, parallel group, 12-week comparison of fluticasone propionate/salmeterol combination Diskus 100/50mcg BID with fluticasone propionate (FP) 250mcg BID as initial maintenance treatment in persistent asthma (Seretide Nordic Jump-Up Study)
Trial description: A double-blind, randomised, parallel group, 12-week comparison of fluticasone propionate/salmeterol combination Diskus 100/50mcg BID with fluticasone propionate (FP) 250mcg BID as initial maintenance treatment in persistent asthma (Seretide Nordic Jump-Up Study)
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: 12 weeks comparing salmeterol/fluticasone proprionate (sfc, 50/100 microg b.d. diskus) versus fluticasone proprionate (fp, 250 microg b.i.diskus) as first-line regular asthma treatment. Oien, T., Tilling, B., and Kotaniemi, J. 13th Annual Congress of the European Respiratory Society 9/27/2003 Vienna; Austria
Abstract: A double blind, randomised, parallel group study over 12 weeks comparing seretide(50/10opg bd diskus) versus flixotide(25opg bd diskus) as first- regular asthma treatment for steroid-naive adult patients. J. Kotaniemi, B. Tilling T. Oien. 99th International Conference of the American Thoracic Society 5/16/2003 Seattle WA
Kotaniemi J, Tilling B, Oien T. A double blind, randomised, parallel group study over 12 weeks comparing Seretide™ (50/100?g bd Diskus™) versus Flixotide™ (250?g bd Diskus™) as first-line regular asthma treatment for steroid-naive adult patients. Am J Respir Crit Care Med 2003; 167 (7): A893
Oien T, Tilling B, Kotaniemi J. 12 weeks comparing salmeterol/fluticasone propionate (SFC, 50/100microg bd Diskus) versus fluticasone proprionate (FP, 250microg bd diskus) as first-line regular asthma treatment. Eur Respir J 2003; 22 (suppl 22): 236s, P1575
Medical condition
Asthma
Product
fluticasone propionate/salmeterol
Collaborators
Not applicable
Study date(s)
November 2000 to October 2001
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2001-08-10
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website